Results 101 to 110 of about 3,169,424 (258)
A Delphi Study on the Management of Neuropathic Cancer Pain in Spain: The DOLNEO Study
Journal of Pain Research, 2022 Concepción Pérez-Hernández,1 María Luz Cánovas,2 Alberto Carmona-Bayonas,3 Yolanda Escobar,4 César Margarit,5 Juan Francisco Mulero Cervantes,6 Teresa Quintanar,7 Ancor Serrano Alfonso,8 Juan Virizuela9 1Pain Unit, Hospital Universitario de la Princesa ...Pérez-Hernández C, Cánovas ML, Carmona-Bayonas A, Escobar Y, Margarit C, Mulero Cervantes JF, Quintanar T, Serrano Alfonso A, Virizuela J +8 moredoaj Predicting levetiracetam neuropsychiatric adverse effects using graph‐theoretical electroencephalographic network metrics in drug‐naive focal epilepsy: A multicenter longitudinal study
Epilepsia, EarlyView.Abstract Objective
Levetiracetam (LEV) is an antiseizure medication approved for focal and generalized epilepsy. Despite its efficacy, neuropsychiatric adverse effects (NP‐AEs) may lead to treatment discontinuation. Quantitative electroencephalographic (qEEG) graph‐theoretical analysis has emerged as a valuable tool for identifying neurophysiological ...Marco Sferruzzi, Lorenzo Ricci, Margherita Anna Grazia Matarrese, Francesca Izzi, Fabio Placidi, Biagio Maria Sancetta, Emanuele Cerulli Irelli, Patrizia Pulitano, Vincenzo Di Lazzaro, Mario Tombini, Giovanni Assenza +10 morewiley +1 more sourceBeyond seizure control: Non–seizure‐related outcomes in focal‐onset epilepsy treated with adjunctive cenobamate. Third interim results from the BLESS study
Epilepsia, EarlyView.Abstract Objective
Cenobamate is approved for treatment of focal seizures in adults, but evidence on non‐seizure outcomes remains limited. This interim statistical analysis of the cenoBamate in aduLts with focal‐onsEt SeizureS (BLESS) study evaluated patient‐ and clinician‐reported outcomes for up to 52 weeks of cenobamate treatment.Simona Lattanzi, Giuseppe d'Orsi, Maria Teresa Di Claudio, Alfredo D'Aniello, Stefano Luca Sensi, Fedele Dono, Mariangela Panebianco, Luigi Sicurella, Alessandra Di Liberto, Andrea Novara, Carlo Di Bonaventura, Paolo Bonanni, Claudio Liguori, Federica Ranzato, Antonio Gambardella, Francesca Bisulli, Patrizia Pulitano, Giada Pauletto, Elena Tartara, Giampaolo Vatti, Giovanni Assenza, Alfonso Giordano, Anna Elisabetta Vaudano, Gionathan Mazza, Angela La Neve, Pietro Pignatta, Simone Beretta, Marianna Pezzella, Michela Cecconi, Chiara Pizzanelli, Vincenzo Andreone, Catello Vollono, Monica Puligheddu, Massimo Gangitano, Daniela Audenino, Nicoletta Foschi, Elisa Fallica, Giovanni Boero, David Stokelj, Maria Pia Pasolini, Luciana Tramacere, Gionata Strigaro, Edoardo Ferlazzo, Tiziano Zanoni, Pietro Penza, Maurizio Elia, Stefano Quadri, Giovanni De Maria, Monica Santo Sabato, Loretta Giuliano, Rosita Galli, Angelo Labate, Filippo Dainese, Giovanni Falcicchio, Roberto De Simone, Michela Procaccini, Valentina Villano, Gabriele Camattari, Daniele Andreis, Lucia Simoni, Giancarlo Di Gennaro, on behalf of the BLESS Study Group, Cecilia Catania, Alessandra Morano, Biagio Orlando, Maria Sole Borioni, Fabrizio Giaculli, Luca Pasquale Giordano, Francesca Pia Mazzeo, Marco Belluzzo, Anna Carmen Nilo, Alessia Peretti, Diana Polo, Anna Bolzan, Giulia Lippa, Marianna Nesta, Lorenzo Ricci, Felice Altieri, Alberto Danieli, Elisa Osanni, Francesco Fortunato, Giuseppe Magro, Laura Marino, Ilaria Sammarra, Francesca Felicia Operto, Carlo Andrea Galimberti, Domenico Lomonaco, Alessia Campomori, Devis Collura, Emanuela Viglietta, Lorenzo Muccioli, Martina Soldà, Veronica Viola, Nicolò Locatelli, Francesca Simonetti, Barbara Mostacci, Roberta Coa, Antonio Valentino Saporito, Vincenzo Belcastro, Valeria Badioni, Maria Grazia Pascarella, Luciano Pellegrino, Angelina Laganà, Rosario Beccore, Orazio Pardeo, Francesco Luppino, Serena Raineri, Stefano Meletti, Niccolò Biagioli, Matteo Pugnaghi, Giada Giovannini, Simona Scolastico, Margherita Burani, Lisa Taruffi, Cecilia Zivelonghi, Umberto Aguglia, Vittoria Cianci, Roberta Cutellè, Angelo Pascarella, Laura Buttarelli, Roberto Matrullo, Davide Toraldo, Chiara Di Blasi, Valeria Sarro, Antonio Volzone, Massimo Di Giovanni, Stefano Avventura, Maria Francesca Tepedino, Andrea Latino, Antonella Morea, Nicola Pilolli, Giuseppe Pontrelli, Luigi Vetri, Giulia Fatati, Sabina Bartalini, Giulia Maccanti, Giulia Beneduce, Damiano Bruno, Giacomo Evangelista, Michelangelo Dasara, Clarissa Corniello, Stefano Consoli, Davide Liviello, Paolo Quintieri, Francesco Habetswallner, Rosaria Renna, Vincenzo Loreto, Edward Cesnik, Carla Marcialis, Martina Romozzi, Costanza Sottani, Matteo Antonucci, Alessio D'Elia, Laura Carmillo, Lavinia Vassallo, Eloise Lo Mauro, Salvatore Maria Lima, Federica Cerasa, Barbara Chiocchetti, Martina Calistri, Andrea Scalvini, Elisabetta Del Zotto, Alice Figura, Giovanni Messina, Marta Maria Tentorio, Paolo Costa, Chiara Silvestri, Elisabetta Rolla, Leandro Purin, Luca Colombo, Morgan Trevisan, Gabriele Mainini, Romano Giovanni Orofino, Matteo Impellizzeri, Maria Cristina Servalli, Paolo Paone, Sara Mazzoleni, Martina Fanella, Teresa Francavilla, Daniele Graziani, Pamela Rosettani, Sara Zagaglia, Luciana Mollo, Azzurra Biagiotti, Alessandro Alesi, Maria Teresa Di Claudio, Pierangela Riani, Fabio Iannaccone, Claudia Scarpitta, Maria Proietto, Angelo Battiato, Salvatore Dominici, Martina Guadagni, Daniela Marino, Rossella Papetti, Marzia Carlini, Lucia Farotti, Marinella Tomaselli, Stefania Pavan, Matteo Cegalin, Elisa Montalenti, Giovanni Battista Rossi, Edoardo Della Sala, Claudio Gojani, Camilla Bertolini, Edoardo Pronello, Francesca Lozza +206 morewiley +1 more sourceEffectiveness and safety of cannabidiol in adult patients with epilepsy: A multicenter, retrospective study
Epilepsia Open, EarlyView.Abstract Objective
Cannabidiol (CBD) has demonstrated promising effectiveness and tolerability as adjunctive treatment in patients with severe childhood epilepsies. This study investigated the effectiveness and tolerability of CBD in adults with a history of Dravet syndrome (DS), Lennox–Gastaut syndrome (LGS), or tuberous sclerosis complex (TSC ...Sara Sánchez‐Gamino, María Isabel Chamorro Muñoz, Pedro J. Serrano‐Castro, Pablo Hernández‐Vitorique, Lucía Rodríguez Jiménez, Yolanda López Moreno, Pablo Cabezudo‐García, Guillermina García Martín +7 morewiley +1 more sourceFenfluramine in Rett syndrome: A multidimensional clinical study
Epilepsia Open, EarlyView.Abstract Objective
Rett syndrome (RTT) is a severe neurodevelopmental disorder frequently associated with drug‐resistant epilepsy, autonomic dysfunction, respiratory abnormalities, sleep disturbances, and behavioral impairment. Fenfluramine has shown efficacy in developmental and epileptic encephalopathies and may provide broader therapeutic benefits ...Elena Gonzalez‐Alguacil, Nuria Lamagrande Casanova, Manuel Luján Bonete, David Mansilla Lozano, Juan José García Peñas, María Ballará Petitbó, Rocío Trincado Lamuño, Verónica Cantarín‐Extremera, Raquel Díaz Conejo, César Rodríguez Sánchez, Adrián García Ron, Víctor Soto Insuga +11 morewiley +1 more sourceCOVID-19 and Severe Asthma: Reflections and Future Solutions [Letter]
Journal of Asthma and Allergy, 2022 Javier Domínguez-Ortega,1,2 Silvia Sánchez-García,3 Carlos Melero Moreno4 1Department of Allergy, Hospital La Paz Institute for Health Research (IdiPAZ), Madrid, Spain; 2CIBER of Respiratory Diseases (CibeRes), Madrid, Spain ...Domínguez-Ortega J, Sánchez-García S, Melero Moreno C +2 moredoaj Preliminary evidence of long‐term safety and effectiveness of anti‐CGRP drugs for migraine prevention in people with comorbid epilepsy: A 52‐week follow‐up retrospective study
Epilepsia Open, EarlyView.Abstract Migraine and epilepsy frequently coexist, but evidence on the safety of calcitonin gene‐related peptide (CGRP)‐targeting therapies in people with epilepsy is lacking. We evaluated long‐term migraine and epilepsy outcomes in a real‐world multicenter retrospective cohort of adults with comorbid migraine and epilepsy treated with anti‐CGRP ...Marina Romozzi, Andrea Burgalassi, Francesco Ceriello, Pietro Martino, Giuliano Sette, Francesca Pistoia, Fabio Placidi, Diego Centonze, Luca Pani, Jacopo Canonichesi, Catello Vollono, Paolo Calabresi, Maria Albanese, Luigi Francesco Iannone +13 morewiley +1 more source